Job/Unit: O20089
/KAP1
Date: 11-04-12 17:17:19
Pages: 11
B. Fraser-Reid et al.
FULL PAPER
The layers were separated, the aqueous phase was extracted with
CH2Cl2, and the combined organic layers were washed with satu-
rated aqueous NaCl. The resulting organic phase was dried with
Na2SO4, filtered, and concentrated. The residue was purified by
flash silica gel column chromatography to afford the corresponding
pure disaccharide. The yields shown for each compound refer to
the acceptor employed in each case. On the other hand, because
two equiv. of donor were used, byproducts arising from the ortho-
ester transformation were commonly detected in the reaction. In
some instances these byproducts were quantified and characterized,
and included the corresponding 1α,1Јβ-disaccharide (i.e., 6) and
methyl glycoside (i.e., 7).
7.25–7.95 (m, 15 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 20.7,
20.8 (ϫ2), 21.0, 28.6, 29.9, 54.9, 62.2, 66.1, 66.6, 68.6, 69.0, 69.3,
69.4, 70.3, 71.2, 72.8, 97.4, 98.3, 114.9, 123.6, 128.4, 128.5, 128.6,
128.7, 129.8, 129.9, 131.5, 133.3, 133.6, 134.3, 137.7, 165.3, 165.7,
169.8, 170.0, 170.7 ppm. API-ES positive: 938.2 [M + Na]+.
C47H49NO18 (915.9): calcd. C 61.63, H 5.39, N 1.53, O 31.44; found
C 61.65, H 5.37, N 1.45.
Pent-4-enyl 3,4-Di-O-benzoyl-6-O-(2,3,4,6-tetra-O-benzoyl-α-
D-
mannopyranosyl)-2-deoxy-2-phthalimido-β- -glucopyranoside (21b):
D
This compound was prepared by the general method from orthoes-
ter 4b (94 mg, 0.15 mmol) and pent-4-enyl 3,4-di-O-benzoyl-
2-deoxy-2-phthalimido-β-d-glucopyranoside
(17,
44.5 mg,
6-O-(2,3,4,6-Tetra-O-acetyl-α-
D
-mannopyranosyl)-1:2,3:4-di-O-iso-
0.076 mmol). Purification by flash chromatography (hexane/EtOAc
8:2) afforded 21b (81.3 mg, 92%) along with methyl glycoside 7b[34]
(16 mg, 17%) and 1α,1β-disaccharide 6b[34] (26 mg, 15%). For 21b:
propylidene-α-
D
-galactopyranoside (20a):[52] This compound was
prepared from orthoester 4a (100 mg, 0.28 mmol) and 1,2:3,4-di-
O-isopropylidene-α-d-galactopyranose (16, 36 mg, 0.138 mmol) by
the general procedure for glycosylation. Purification by flash
chromatography (hexane/EtOAc 6:4) afforded 20a (67 mg, 82%),
the spectroscopic data for which are identical to those described
previously.[52] 1H NMR (300 MHz, CDCl3): δ = 1.32 (s, 6 H), 1.41
(s, 3 H), 1.55 (s, 3 H), 1.98 (s, 3 H), 2.03 (s, 3 H), 2.09 (s, 3 H),
2.15 (s, 3 H), 3.70 (dd, J = 10.2, 6.4 Hz, 1 H), 3.78 (dd, J = 10.2,
6.2 Hz, 1 H), 3.94–3.96 (m, 1 H), 4.06–4.11 (m, 2 H), 4.24 (dd, J
= 7.9, 1.7 Hz, 1 H), 4.29–4.33 (m, 2 H), 4.61 (dd, J = 7.9, 2.4 Hz,
1
[α]D = –12.7 (c = 1.0, CHCl3). H NMR (300 MHz, CDCl3): δ =
1.42–1.60 (m, 2 H), 1.78–1.85 (m, 2 H), 3.55 (dt, J = 9.8, 6.5 Hz,
1 H), 3.70 (dd, J = 10.5, 1.7 Hz, 1 H), 3.92 (dt, J = 9.8, 6.1 Hz, 1
H), 4.03 (dd, J = 10.5, 6.4 Hz, 1 H), 4.13 (m, 1 H), 4.27 (dd, J =
12.0, 4.7 Hz, 1 H), 4.37 (ddd, J = 9.6, 4.6, 2.2 Hz, 1 H), 4.47 (d, J
= 8.8 Hz, 1 H), 4.49 (t, J = 10.9 Hz, 1 H), 4.63 (m, 2 H), 5.04 (d,
J = 1.3 Hz, 1 H), 5.52 (d, J = 8.4 Hz, 1 H), 5.42–5.56 (m, 1 H),
5.65 (dd, J = 3.2, 1.7 Hz, 1 H), 5.88 (dd, J = 10.1, 3.2 Hz, 1 H),
5.98 (t, J = 9.9 Hz, 1 H), 6.23 (dd, J = 10.1, 9.9 Hz, 1 H), 7.16–
1 H), 4.86 (d, J = 1.2 Hz, 1 H), 5.22–5.34 (m, 3 H), 5.49 (d, J = 8.03 (m, 35 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 28.7, 30.0,
5.0 Hz, 1 H) ppm.
55.1, 62.8, 66.9, 67.0, 69.1, 69.4, 70.1, 70.4, 70.5, 71.4, 73.0, 97.6,
98.4, 114.9, 123.7, 128.4 (ϫ4), 128.5 (ϫ4), 128.6 (ϫ8), 128.7 (ϫ4),
128.8 (ϫ2), 129.2 (ϫ2), 129.3, 129.4, 129.8 (ϫ4), 129.9 (ϫ8), 131.6
(ϫ2), 133.1, 133.2, 133.3, 133.5, 133.6, 134.3, 137.8, 165.4 (ϫ3),
165.6, 165.8, 166.2 ppm. API-ES positive: 1187.1 [M + Na]+.
C67H57NO18 (1164.2): calcd. C 69.12, H 4.94, N 1.20; found C
69.20, H 4.90, N 1.22.
6-O-(2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranosyl)-1:2,3:4-di-O-iso-
propylidene-α-D
-galactopyranoside (20b):[53] This compound was
prepared by the general method from orthoester 4b (171 mg,
0.28 mmol) and 1,2:3,4-di-O-isopropylidene-α-d-galactopyranose
(16, 20 mg, 0.138 mmol). Purification by flash chromatography
(hexane/EtOAc 7:3) afforded 20b (63 mg, 99%) along with methyl
glycoside 7b[34] (48 mg, 28%) and 1α,1Јβ-disaccharide 6b[34] (39 mg,
12%). The spectral data for 20b are in agreement with those de-
scribed previously.[53] 1H NMR (300 MHz, CDCl3): δ = 1.36 (s, 3
Phenyl 6-O-(2,3,4,6-Tetra-O-acetyl-α-
O-methyl-1-thio-α- -mannopyranoside (22a): This compound was
prepared from orthoester 4a (100 mg, 0.276 mmol) and phenyl
(18, 50 mg,
D-mannopyranosyl)-2,3,4-tri-
D
H), 1.43 (s, 3 H), 1.63 (s, 3 H), 3.90 (dd, J = 10.4, 6.0 Hz, 1 H), 2,3,4-tri-O-methyl-1-thio-α-d-glucopyranoside
3.98 (dd, J = 10.4, 6.3 Hz, 1 H), 4.07–4.17 (m, 1 H), 4.32–4.39 (m,
2 H), 4.51 (dd, J = 12.1, 3.9 Hz, 1 H), 4.57–4.64 (m, 1 H), 4.65–
4.73 (m, 2 H), 5.17 (d, J = 1.8 Hz, 1 H), 5.57 (d, J = 5.0 Hz, 1 H),
5.75 (dd, J = 3.2, 1.8 Hz, 1 H), 5.92 (dd, J = 10.1, 3.3 Hz, 1 H),
0.138 mmol) by the general procedure for glycosylation. Purifica-
tion by flash chromatography (hexane/EtOAc 6:4) afforded 17a
(65 mg, 73%). [α]D = +81.4 (c = 0.4, CHCl3). 1H NMR (300 MHz,
CDCl3): δ = 1.99 (s, 3 H), 2.05 (s, 3 H), 2.10 (s, 3 H), 2.14 (s, 3 H),
6.14 (t, J = 10.0 Hz, 1 H), 7.24–7.62 (m, 12 H), 7.83–8.14 (m, 8 3.46 (s, 3 H), 3.48 (m, 1 H), 3.49 (m, 1 H), 3.52 (s, 3 H), 3.56 (s, 3
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 24.5, 25.1, 26.1, 26.3,
63.0, 66.8, 66.9, 67.7, 68.9, 70.3, 70.5, 70.8 (ϫ2), 71.1, 96.5, 98.0,
108.9, 109.6, 128.4 (ϫ2), 128.5 (ϫ4), 128.7 (ϫ 2), 129.2, 129.3,
129.5, 129.8 (ϫ2), 129.9 (ϫ4), 130.0 (ϫ2), 130.1, 133.1, 133.2,
133.5 (ϫ2), 165.5 (ϫ2), 165.6, 166.3 ppm.
H), 3.75 (dd, J = 11.1, 1.8 Hz, 1 H), 3.86 (t, J = 1.9 Hz, 1 H), 3.91
(dd, J = 11.1, 5.8 Hz, 1 H), 4.04 (ddd, J = 9.4, 5.0, 2.1 Hz, 1 H),
4.11 (dd, J = 12.2, 2.2 Hz, 1 H, 1 H), 4.15–4.22 (m, 1 H), 4.26 (dd,
J = 12.2, 5.1 Hz, 1 H), 4.93 (d, J = 1.5 Hz, 1 H), 5.27 (t, J = 9.8 Hz,
1 H), 5.31 (dd, J = 3.2, 1.5 Hz, 1 H), 5.35 (dd, J = 9.8, 3.2 Hz, 1
H), 5.59 (d, J = 1.9 Hz, 1 H), 7.24–7.51 (m, 5 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 20.8, 20.9 (ϫ2), 21.1, 57.6, 58.1, 61.0, 62.4,
66.4, 67.2, 68.5, 69.1, 69.6, 72.0, 76.5, 78.4, 81.7, 84.7, 97.9, 127.7,
129.3 (ϫ2), 131.6 (ϫ2), 134.5, 169.7, 169.9, 170.0, 170.8 ppm. API-
ES positive: 667.2 [M + Na]+. C29H40O14S (664.68): calcd. C 54.03,
H 6.25, S 4.97; found C 54.07, H 6.27, S 4.79.
Pent-4-enyl 3,4-Di-O-benzoyl-6-O-(2,3,4,6-tetra-O-acetyl-α-
D-man-
nopyranosyl)-2-deoxy-2-phthalimido-β- -glucopyranoside (21a):
D
This compound was prepared from orthoester 4a (100 mg,
0.276 mmol) and pent-4-enyl 3,4-di-O-benzoyl-2-deoxy-2-phthal-
imido-β-d-glucopyranoside (17, 81 mg, 0.138 mmol) by the general
procedure for glycosylation. Purification by flash chromatography
(hexane/EtOAc 6:4) afforded 21a (112 mg, 87%). [α]D = +42.6 (c =
Phenyl 6-O-(2,3,4,6-Tetra-O-benzoyl-α-
D-mannopyranosyl)-2,3,4-
1
1.0, CHCl3). H NMR (300 MHz, CDCl3): δ = 1.58 (dq, J = 13.9,
tri-O-methyl-1-thio-α- -mannopyranoside (22b): This compound
D
7.5 Hz, 2 H), 1.90 (m, 2 H), 1.98 (s, 3 H), 2.01 (s, 3 H), 2.05 (s, 3
H), 2.12 (s, 3 H), 3.54 (dt, J = 9.8, 6.6 Hz, 1 H), 3.67 (dd, J = 10.8,
2. 3 Hz, 1 H), 3.88–4.03 (m, 4 H), 4.13 (ddd, J = 9.3, 6.6, 2.3 Hz,
1 H), 4.20 (dd, J = 12.1, 5.1 Hz, 1 H), 4.56 (dd, J = 10.8, 8.4 Hz,
was prepared by the general method from orthoester 4b (168 mg,
0.28 mmol) and phenyl 2,3,4-tri-O-methyl-1-thio-α-d-glucopyran-
oside (18, 50 mg, 0.138 mmol). Purification by flash chromatog-
raphy (hexane/EtOAc 7:3) afforded 22b (117 mg, 95%). [α]D = +7.8
1
1 H), 4.77 (m, 1 H), 4.85 (d, J = 1.6 Hz, 1 H), 5.26 (t, J = 10.0 Hz, (c = 0.6, CHCl3). H NMR (300 MHz, CDCl3): δ = 3.41 (s, 3 H),
1 H), 5.27 (dd, J = 3.5, 1.7 Hz, 1 H), 5.38 (dd, J = 10.1, 3.5 Hz, 1
H), 5.53 (dd, J = 10.1, 9.3 Hz, 1 H), 5.54 (d, J = 8.4 Hz, 1 H), 5.62
(ddt, J = 17.0, 10.3, 6.7 Hz, 1 H), 6.27 (dd, J = 10.8, 9.2 Hz, 1 H),
3.47–3.49 (m, 2 H), 3.48 (s, 3 H), 3.53 (s, 3 H), 3.82 (m, 2 H), 4.01
(dd, J = 11.0, 6.0 Hz, 1 H), 4.23 (m, 1 H), 4.41 (m, 2 H), 4.59 (dd,
J = 13.7, 4.3 Hz, 1 H), 5.13 (d, J = 1.8 Hz, 1 H), 5.58 (d, J =
8
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0